Scarica l'app Stockscreener
6.58
0.30%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MYGN Giù?
Forum
Previsione
Frazionamento azionario
Myriad Genetics Inc Borsa (MYGN) Ultime notizie
What Analysts Think Is Shaping The Story For Myriad Genetics (MYGN) Now - Yahoo Finance
Can Myriad Genetics Inc. stock outperform in 2025 bull market2025 Short Interest & Growth-Oriented Investment Plans - ulpravda.ru
Is Myriad Genetics Inc. (MYD) stock a good hedge against inflationJuly 2025 Highlights & Capital Protection Trading Alerts - ulpravda.ru
Will Myriad Genetics Inc. stock benefit from infrastructure spending2025 Geopolitical Influence & Verified Trade Idea Suggestions - ulpravda.ru
Can Myriad Genetics Inc. (MYD) stock surprise with quarterly resultsQuarterly Investment Review & Consistent Return Strategy Ideas - ulpravda.ru
Clinical Laboratory Services Market is expected to reach US$ - openPR.com
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Is Myriad Genetics Inc a good long term investmentMid Cap Growth Trends & Free Discover Massive Upside Stocks - earlytimes.in
The Truth About Myriad Genetics Inc: Is This DNA Stock a Sleeper Goldmine or Just Overhyped? - AD HOC NEWS
What analysts say about Myriad Genetics Inc stockPrice Gap Trading Strategies & Free Unmatched Market Gains - earlytimes.in
Should Myriad Genetics stock stay in your portfolio right now? - MSN
Myriad Genetics Inc Stock Analysis and ForecastHealthcare Stock Analysis & Small Investment Portfolio Tips - earlytimes.in
Precision Trading with Myriad Genetics Inc. (MYGN) Risk Zones - Stock Traders Daily
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Should Myriad Genetics Stock Stay in Your Portfolio Right Now? - Yahoo Finance
Myriad Genetics (NASDAQ:MYGN) Share Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Pancreatic Cancer Market is projected to reach US$ 5.7 billion - openPR.com
Myriad Genetics and MD Anderson partner to evaluate molecular residual disease assay - MSN
Looking at the Narrative for Myriad Genetics After Price Target Revisions and Growth Concerns - Yahoo Finance
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why - Finviz
Can Myriad Genetics Inc. stock sustain revenue growth2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Avoiding Lag: Real-Time Signals in (MYGN) Movement - news.stocktradersdaily.com
Myriad Genetics, Inc. $MYGN Shares Bought by Assenagon Asset Management S.A. - MarketBeat
What insider trading reveals about Myriad Genetics Inc. stockMarket Performance Recap & Intraday High Probability Alerts - Улправда
Sell Signal: Can Myriad Genetics Inc. (MYD) stock surprise with quarterly results2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Is Myriad Genetics Inc. stock vulnerable to regulatory risksEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
Will Myriad Genetics Inc. stock attract more institutional investorsWeekly Trend Recap & Capital Efficient Trading Techniques - Улправда
Why Myriad Genetics Inc. stock is in analyst buy zoneOptions Play & Daily Entry Point Trade Alerts - Улправда
Myriad Genetics, Inc. (NASDAQ:MYGN) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛
Zydus Lifesciences signs agreement with Myriad Genetics for cancer-risk tests in India - marketscreener.com
J.P. Morgan Healthcare Conference - marketscreener.com
Parp Inhibitor Biomarkers Market Forecast Through 2032 - openPR.com
Cancer Diagnostics Market is Going to Boom: New Report Reveals - openPR.com
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Myriad Genetics Earnings Notes - Trefis
Chart Watch: Why Myriad Genetics Inc stock could rally in 2025Weekly Investment Report & Low Drawdown Trading Strategies - moha.gov.vn
Myriad Genetics (MYGN) CEO discloses 29,634-share tax withholding - Stock Titan
Will Breakout in GIC Housing Finance Limited Sustain Through Next WeekCapital Gains Strategies & Free Unmatched Market Gains - earlytimes.in
Myriad Genetics, Inc. $MYGN Stake Reduced by Camber Capital Management LP - MarketBeat
Myriad Genetics Q3 2025 Earnings Preview - MSN
Discipline and Rules-Based Execution in MYGN Response - news.stocktradersdaily.com
Why Myriad Genetics (MYGN) Stock Is Up Today - Finviz
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium - The Manila Times
Myriad Genetics to Showcase Advances in Hereditary Cancer and MRD Testing at 2025 San Antonio Breast Cancer Symposium - Quiver Quantitative
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Prudential Financial Inc. Has $1.82 Million Stock Position in Myriad Genetics, Inc. $MYGN - MarketBeat
Fisher Asset Management LLC Purchases 219,607 Shares of Myriad Genetics, Inc. $MYGN - MarketBeat
What MACD trends signal for Myriad Genetics Inc. (MYD) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
1.12%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):